Congress acknowledges colorectal cancer kills Black Americans at twice the rate
H.Res. 239 — Raising awareness of the racial disparities in the impact of colorectal cancer on the Black community. · Filed by Bonnie Watson Coleman (D-NJ) · 10 cosponsors · Introduced Mar 21, 2025 · Referred to committee
Your members of Congress
Enter a ZIP to see where your representative and both senators stood on this bill.
Looked up on this device — your ZIP is never stored on our servers.
What it does
This House resolution acknowledges that Black Americans die from colorectal cancer at significantly higher rates than white Americans and calls on federal health agencies (CDC, NIH) and state insurance plans to expand screening programs, conduct research into causes of the disparity, and lower screening age thresholds—particularly for Black communities. The resolution is non-binding and contains no new funding or regulatory mandates, but signals congressional support for addressing a documented public health inequity.
Why we flagged it
This is a straightforward House resolution acknowledging racial disparities in colorectal cancer outcomes and encouraging public health agencies and insurers to expand screening and research efforts. It contains no legislative mandates, appropriations, or regulatory changes—purely hortatory language.
What the text implies
- May indirectly increase demand for colorectal cancer screening services and diagnostics.
- State health plan coverage expansions could increase costs for insurers and state budgets.
The full analysis lists 3 implications of this text.
Who stands to gain
colorectal cancer screening service providers; diagnostic imaging and laboratory companies; pharmaceutical companies with oncology portfolios